Featured Story | By Nick Paul Taylor Roche has taken the lead in the race to bring subcutaneous checkpoint inhibitors to market in the West, reporting phase 3 results that tee it up to file for approval in the U.S. and the EU. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor What is the economic impact of introducing an oral version of an intravenous drug? That is the health economics question at the heart of a paper by researchers at RTI Health Solutions and Mitsubishi Tanabe Pharma. The answer? It’s complicated. read more By Nick Paul Taylor Cure Pharmaceutical is cashing in some of its drug delivery intellectual property, selling patents covering film-based drug delivery to TF Tech Ventures in a deal worth $20 million. read more By Angus Liu Antivirals have historically made up the bulk of licenses that allow generics companies to copy innovative drugs for poorer countries. Now, GSK’s ViiV Healthcare is adding the world’s first long-acting HIV prevention med to a patent-sharing program merely seven months into an FDA approval. read more By Angus Liu Pfizer's Eucrisa never lived to become the next big topical treatment for inflammatory skin diseases. Now, young biotech Arcutis Biotherapeutics is bringing along a new therapy that goes after the same drug target but with a very different product profile. read more By Ben Adams Pharma’s reputation may have soared amid the pandemic, but that came with a brighter spotlight on DEI issues. In recent years, pharma has been trying to penetrate social issues of diversity, equity and inclusion more deeply into its corporate psyche. read more By Teresa Carey This week on "The Top Line," we discuss how to move forward from Alzheimer's latest drug development setback and what the industry needs to do to make a real environmental difference. We also chat about how AI in drug R&D is growing up and ways to handle the cell and gene therapies' sticker shock. read more Resources Sponsored by: Thermo Fisher Scientific See how integration of innovative genetic analysis techniques into drug development is driving biopharma & biotech companies ahead. Sponsored by: Nexelis Discover Nexelis’ first-hand perspective on how to develop innovative, agile solutions in vaccine efficacy testing in this exclusive e-book. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent Orally Inhaled & Nasal Drug Delivery: A Pipeline of Opportunities Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. | 
